COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature
We report the pooled incidence of AIS in COVID-19 patients to be 1.2%, with a high mortality rate. Elevatedd-dimer, fibrinogen and the presence of antiphospholipid antibodies appear to be prominent in COVID-19 patients with concomitant AIS, but further mechanistic studies are required to elucidate their role in pathogenesis.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Antiphospholipid Syndrome | Brain | Coronavirus | COVID-19 | Hematology | Hughes Syndrome | Ischemic Stroke | Laboratory Medicine | Neurology | Stroke | Study | Thrombosis